Self-assembled hyaluronic acid nanoparticles (HA-NPs), consisting of hydrophobic cores surrounded by a hydrophilic HA shell, have been extensively investigated for biomedical and pharmaceutical applications because of their biocompatibility and receptor-binding properties. Here, we report that an empty HA-NP itself not bearing any drug has therapeutic effects on adipose tissue inflammation and insulin resistance. HA-NPs inhibit not only the receptor-mediated internalization of low-molecular-weight (LMW) free HA but also LMW free HA-induced pro-inflammatory gene expression in mouse primary bone marrow-derived macrophages (BMDMs) isolated from wild type mice. Following systemic administration of Cy5.5-labeled HA-NPs, in vivo biodistribution assay and immunofluorescent staining indicate the distribution of HA-NPs and their co-localization with CD44 in adipose tissues including epididymal white adipose tissue (eWAT). However, these effects are largely reduced or rarely observed in BMDMs isolated from CD44-deficient mice. In addition, diet-induced obese (DIO) mice fed a high-fat diet (HFD) show elevated CD44 expression and HA-NP accumulation in eWAT compared to mice on standard diet. Treatment with HA-NPs in HFD-fed DIO mice suppresses macrophage infiltration into adipose tissue and adipose tissue inflammation, leading to improved insulin sensitivity and glycemic control. It is revealed that HA-NP itself can be a therapeutic agent for the treatment of type 2 diabetes.

Disclosure

J. Rho: None. W. Lee: None. E. Lee: None. C. Kim: None. E. Lee: None. W. Kim: None.

© 2018 by the American Diabetes Association.
2018
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.